A model developed by LMU biophysicists demonstrates how biological processes form the convoluted internal architecture of the ...

Kennedy researchers have uncovered key design parameters for bispecific T-cell engagers (TcEs)—a class of cancer ...

EMERYVILLE, Calif.--(BUSINESS WIRE)--Eureka Therapeutics, Inc., a clinical-stage biotechnology company developing novel T cell therapies to treat solid tumors, today announced the publication of a ...

Despite the remarkable efficacy of CAR-T cell therapies to treat certain blood ... The spongelike structure is also sprinkled with antibodies to activate the T cells and the cytokine IL-2 to ...

CAR-T cells are, in essence, T-lymphocytes equipped with a next-generation membrane receptor: a structure specifically designed to recognize and attack tumor cells with a precision and sensitivity ...

Researchers have developed synthetic T lymphocytes, or T cells, that are near-perfect facsimiles of human T cells. Their artificial cell could be a key step toward more effective drugs to treat ...

Anaplastic large cell lymphoma (ALCL) belongs to the subgroup of non-Hodgkin's lymphomas and is a rare but aggressive form of T-cell lymphoma that usually occurs in children and young adults.

Peripheral T-cell lymphoma is a rare and aggressive type of cancer that affects mature T cells. Learn more ... research from 2020 mentions that changes in the DNA’s structure causing ...

After CAR T-cell therapy, all 10 patients had complete remission with incomplete hematologic recovery and grade 4 pancytopenia. After haploidentical HSCT, 1 patient died on day 13 of septic shock ...